1. Medicines and Healthcare Products Regulatory Agency. Regulatory approval of Ronapreve. 20 Aug 2021. https://www.gov.uk/government/publications/regulatory-approval-of-ronapreve
2. Roche. Japan becomes first country to approve Ronapreve (casirivimab and imdevimab) for the treatment of mild to moderate covid-19. 20 Jul 2021. https://www.roche.com/de/media/releases/med-cor-2021-07-20.htm
3. Covid-19: Regeneron’s antibody combination cuts deaths in seronegative patients, trial finds